Kangmei Pharmaceutical Co (SHSE:600518) Long-Term Capital Lease Obligation : ¥187 Mil (As of Mar. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Kangmei Pharmaceutical Co Long-Term Capital Lease Obligation?

Kangmei Pharmaceutical Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was ¥187 Mil.

Kangmei Pharmaceutical Co's quarterly Long-Term Capital Lease Obligation declined from Sep. 2023 (¥196 Mil) to Dec. 2023 (¥188 Mil) and declined from Dec. 2023 (¥188 Mil) to Mar. 2024 (¥187 Mil).

Kangmei Pharmaceutical Co's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (¥153 Mil) to Dec. 2022 (¥199 Mil) but then declined from Dec. 2022 (¥199 Mil) to Dec. 2023 (¥188 Mil).

Kangmei Pharmaceutical Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Kangmei Pharmaceutical Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangmei Pharmaceutical Co Long-Term Capital Lease Obligation Chart

Kangmei Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

Get a 7-Day Free Trial

140.64

153.22

199.13

188.16

Kangmei Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial															189.63	199.68	195.86	188.16	186.62

Kangmei Pharmaceutical Co (SHSE:600518) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Kangmei Pharmaceutical Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Kangmei Pharmaceutical Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Kangmei Pharmaceutical Co (SHSE:600518) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kangmei Pharmaceutical Co Ltd (SHSE:600518) » Definitions » Long-Term Capital Lease Obligation

Traded in Other Exchanges

N/A

Address

No. 3, Taike Road, Xiameilin, Futian District, Shenzhen, CHN, 518000

Website

http://www.kangmei.com.cn

Kangmei Pharmaceutical Co Ltd is a pharmaceutical company engaged in the manufacturing, research and marketing of herbal medicine and chemical raw materials.

Executives

Xu Dong Jin	Director
Li Jian Hua	senior management
Qiu Xi Wei	Director
Wang Min	senior management
Peng Qin	senior management
Ma Xing Tian	Director
Lin Guo Xiong	senior management
Zhuang Yi Qing	senior management
Wen Shao Sheng	Supervisors

Kangmei Pharmaceutical Co (SHSE:600518) Headlines

No Headlines